Basic Information
ID: ALA3541623
Type: ADME
Description: Drug metabolism in human whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3-nitroazetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method
Format: BAO_0000221
Organism: Homo sapiens
Tissue: Blood
Target: Whole blood(ALA2367389)
Document: ALA3526110
Drug metabolism in human whole blood assessed as [(S)-2-amino-5-(((R)-1-((carboxymethyl)amino)-3-((2-(3-nitroazetidin-1-yl)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-5-oxopentanoic acid] formation at 20 uM by LC-MS/MS method: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3541623
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 268.02 | -0.53 | -0.53 |